Hypothetical hormonal mechanism by which potassium-rich diets benefit patients with rheumatoid arthritis

Medical Hypotheses

Volumn 73, Issue 4, 2009, Pages 564-568

  Rastmanesh, Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROXYCHLOROQUINE; INTERLEUKIN 6; METHOTREXATE; NEUROPEPTIDE Y; PLACEBO; POTASSIUM CHLORIDE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYTOKINE RELEASE; DIET SUPPLEMENTATION; GENOMICS; HIGH POTASSIUM INTAKE; HORMONAL REGULATION; HUMAN; HYDROCORTISONE RELEASE; HYPOKALEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; POTASSIUM BALANCE; POTASSIUM BLOOD LEVEL; POTASSIUM DEFICIENCY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYMPATHETIC TONE;

ARTHRITIS, RHEUMATOID; DIETARY SUPPLEMENTS; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, BIOLOGICAL; PITUITARY-ADRENAL SYSTEM; POTASSIUM, DIETARY;

EID: 69249215148     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.05.035     Document Type: Article

References (99)

1. Medical Research Council. Diet and Arthritis. Hughes J, Lang R, Thane CW, Bolton-Smith C, Jebb SA. 2001. Arthritic Association. 8-30-0080. Ref Type: Report.
2. DeCoti-Marsh C. Home treatment for arthritis. 13th ed. (2000), Amberwood Publishing Ltd., Eastbourne, East Sussex
3. Hafstrom I., Ringertz B., Spangberg A., von Z.L., Brannemark S., Nylander I., et al. A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford) 40 (2001) 1175-1179
4. Kjeldsen-Kragh J., Haugen M., Borchgrevink C.F., Laerum E., Eek M., Mowinkel P., et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 338 (1991) 899-902
5. Kjeldsen-Kragh J., Hvatum M., Haugen M., Forre O., and Scott H. Antibodies against dietary antigens in rheumatoid arthritis patients treated with fasting and a one-year vegetarian diet. Clin Exp Rheumatol 13 (1995) 167-172
6. Skoldstam L., Larsson L., and Lindstrom F.D. Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol 8 (1979) 249-255
7. Skoldstam L., Hagfors L., and Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 62 (2003) 208-214
8. Skoldstam L., Brudin L., Hagfors L., and Johansson G. Weight reduction is not a major reason for improvement in rheumatoid arthritis from lacto-vegetarian, vegan or Mediterranean diets. Nutr J 4 (2005) 15-21
9. Keysser G. Are there effective dietary recommendations for patients with rheumatoid arthritis?. Z Rheumatol 60 (2001) 17-27
10. Hanninen O., Kaartinen K., Rauma A.L., Nenonen M., Torronen R., Hakkinen A.S., et al. Antioxidants in vegan diet and rheumatic disorders. Toxicology 155 (2000) 45-53
11. Rastmanesh R., Abargouei A.S., Shadman Z., Ebrahimi A.A., and Weber C.E. A pilot study of potassium supplementation in the treatment of hypokalemic patients with rheumatoid arthritis: a randomized, double-blinded, placebo-controlled trial. J Pain 9 (2008) 722-731
12. Leitzmann C. Vegetarian diets: what are the advantages?. Forum Nutr (2005) 147-156
13. DeCoti-Marsh C. Rheumatism and arthritis: the conquest. London: Thorson's Publishers Ltd.; 1957.
14. Weber C.E. Potassium in the etiology of rheumatoid arthritis and heart infarction. J Appl Nutr (2007) 41-67
15. Saxena K. Clinical features and management of poisoning due to potassium chloride. Med Toxicol Adverse Drug Exp 4 (1989) 429-443
16. Ifudu O., Markell M.S., and Friedman E.A. Unrecognized pseudohyperkalemia as a cause of elevated potassium in patients with renal disease. Am J Nephrol 12 (1992) 102-104
17. Rall L.C., Rosen C.J., Dolnikowski G., Hartman W.J., Lundgren N., Abad L.W., et al. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha. Arthritis Rheum 39 (1996) 1115-1124
18. Sambrook P.N., Ansell B.M., Foster S., Gumpel J.M., Hesp R., Reeve J., et al. Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Ann Rheum Dis 44 (1985) 575-579
19. Bia M.J., and DeFronzo R.A. Extrarenal potassium homeostasis. Am J Physiol 240 (1981) F257-F268
20. Kleeman C.R., Levi J., and Better O. Kidney and adrenocortical hormones. Nephron 15 (1975) 261-278
21. Melby J.C., and Dale S.L. New mineralocorticoids and adrenocorticosteroids in hypertension. Am J Cardiol 38 (1976) 805-813
22. Melby J.C., and Dale S.L. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension. Mayo Clin Proc 52 (1977) 317-322
23. Weber C.E. Corticosteroid regulation of electrolytes. J Theor Biol 104 (1983) 443-449
24. DeFronzo R.A., Taufield P.A., Black H., McPhedran P., and Cooke C.R. Impaired renal tubular potassium secretion in sickle cell disease. Ann Intern Med 90 (1979) 310-316
25. Crofford L.J., Kalogeras K.T., Mastorakos G., Magiakou M.A., Wells J., Kanik K.S., et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82 (1997) 1279-1283
26. Cutolo M., Foppiani L., Prete C., Ballarino P., Sulli A., Villaggio B., et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 26 (1999) 282-288
27. Demir H., Kelestimur F., Tunc M., Kirnap M., and Ozugul Y. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 28 (1999) 41-46
28. Gudbjornsson B., Skogseid B., Oberg K., Wide L., and Hallgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol 23 (1996) 596-602
29. Gutierrez M.A., Garcia M.E., Rodriguez J.A., Mardonez G., Jacobelli S., and Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 26 (1999) 277-281
30. Hall J., Morand E.F., Medbak S., Zaman M., Perry L., Goulding N.J., et al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum 37 (1994) 1132-1137
31. Harle P., Straub R.H., Wiest R., Mayer A., Scholmerich J., Atzeni F., et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis 65 (2006) 51-56
32. Kanik K.S., Chrousos G.P., Schumacher H.R., Crane M.L., Yarboro C.H., and Wilder R.L. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab 85 (2000) 1461-1466
33. Templ E., Koeller M., Riedl M., Wagner O., Graninger W., and Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 35 (1996) 350-356
34. van den Brink H.R., Blankenstein M.A., Koppeschaar H.P., and Bijlsma J.W. Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis. Clin Exp Rheumatol 11 (1993) 649-652
35. Syrjanen S., Lappalainen R., and Markkanen H. Salivary and serum levels of electrolytes and immunomarkers in edentulous healthy subjects and in those with rheumatoid arthritis. Clin Rheumatol 5 (1986) 49-55
36. Cockel R., Kendall M.J., Becker J.F., and Hawkins C.F. Serum biochemical values in rheumatoid disease. Ann Rheum Dis 30 (1971) 166-170
37. Huisman A.M., van Everdingen A.A., Wenting M.J., Siewertsz Van Reesema D.R., Lafeber F.P., Jacobs J.W., et al. Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis. Ann N Y Acad Sci 966 (2002) 64-67
38. van Everdingen A.A., Huisman A.M., Wenting M.J., van R.S., Jacobs J.W., and Bijlsma J.W. Down regulation of glucocorticoid receptors in early-diagnosed rheumatoid arthritis. Clin Exp Rheumatol 20 (2002) 463-468
39. Schmidt M., Weidler C., Naumann H., Anders S., Scholmerich J., and Straub R.H. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?. Arthritis Rheum 52 (2005) 1711-1720
40. Rainey W.E. Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase. Mol Cell Endocrinol 151 (1999) 151-160
41. Harbuz M.S., Korendowych E., Jessop D.S., Crown A.L., Li pdfan S.L., and Kirwan J.R. Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test. J Endocrinol 178 (2003) 55-60
42. Jorgensen C., Bressot N., Bologna C., and Sany J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol 22 (1995) 1829-1833
43. Straub R.H., Paimela L., Peltomaa R., Scholmerich J., and Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 46 (2002) 654-662
44. Straub R.H., Pongratz G., Cutolo M., Wijbrandts C.A., Baeten D., Fleck M., et al. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum 58 (2008) 976-984
45. Kirwan J., and Power L. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Curr Opin Rheumatol 19 (2007) 233-237
46. Cutolo M., Sulli A., Pizzorni C., Secchi M.E., Soldano S., Seriolo B., et al. Circadian rhythms: glucocorticoids and arthritis. Ann N Y Acad Sci 1069 (2006) 289-299
47. Mastorakos G., and Ilias I. Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis. Z Rheumatol 59 Suppl. 2 (2000) II/75-II/79
48. Buckbinder L., and Robinson R.P. The glucocorticoid receptor: molecular mechanism and new therapeutic opportunities. Curr Drug Targets Inflamm Allergy 1 (2002) 127-136
49. Bird I.M., Mathis J.M., Mason J.I., and Rainey W.E. Ca(2+)-regulated expression of steroid hydroxylases in H295R human adrenocortical cells. Endocrinology 136 (1995) 5677-5684
50. Li L.A., and Lin T.C. Interacting influence of potassium and polychlorinated biphenyl on cortisol and aldosterone biosynthesis. Toxicol Appl Pharmacol 220 (2007) 252-261
51. Fraser R., Holloway C.D., and Kenyon C.J. Inhibition of corticosteroid 11 beta hydroxylation in bovine zona fasciculata cells by the potassium entry blocker 4-aminopyridine. J Steroid Biochem 24 (1986) 777-778
52. Robba C., Rebuffat P., Mazzocchi G., and Nussdorfer G.G. The possible potassium involvement in the modulation of the long-term trophic action of ACTH on the rat adrenal zona fasciculata. Exp Clin Endocrinol 86 (1985) 371-374
53. Tremblay A., and LeHoux J.G. Transcriptional activation of adrenocortical steroidogenic genes by high potassium or low sodium intake. FEBS Lett 317 (1993) 211-215
54. Aguilera G., and Catt K.J. Loci of action of regulators of aldosterone biosynthesis in isolated glomerulosa cells. Endocrinology 104 (1979) 1046-1052
55. Kramer R.E., Gallant S., and Brownie A.C. The role of cytochrome P-450 in the action of sodium depletion on aldosterone biosynthesis in rats. J Biol Chem 254 (1979) 3953-3958
56. Muller J. 11 Beta-hydroxylation of 18-hydroxy-11-deoxycorticosterone by rat adrenal tissue: zone specificity and effect of sodium and potassium restriction. J Steroid Biochem 13 (1980) 253-257
57. Tremblay A., and LeHoux J.G. Effects of dietary sodium restriction and potassium intake on cholesterol side-chain cleavage cytochrome P-450 and adrenodoxin mRNA levels. J Steroid Biochem 34 (1989) 385-390
58. Tremblay A., Waterman M.R., Parker K.L., and LeHoux J.G. Regulation of rat adrenal messenger RNA and protein levels for cytochrome P-450s and adrenodoxin by dietary sodium depletion or potassium intake. J Biol Chem 266 (1991) 2245-2251
59. Bureik M., Lisurek M., and Bernhardt R. The human steroid hydroxylases CYP1B1 and CYP11B2. Biol Chem 383 (2002) 1537-1551
60. Gluck T., Oertel M., Reber T., Zietz B., Scholmerich J., and Straub R.H. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. I. The hypothalamus-autonomic nervous system axis. J Rheumatol 27 (2000) 903-910
61. Kuis W., de Jong-de Vos van Steenwijk C.C.E., Sinnema G., Kavelaars A., Prakken B., Helders P.J., et al. The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav Immun 10 (1996) 387-398
62. Leden I., Eriksson A., Lilja B., Sturfelt G., and Sundkvist G. Autonomic nerve function in rheumatoid arthritis of varying severity. Scand J Rheumatol 12 (1983) 166-170
63. Perry F., Heller P.H., Kamiya J., and Levine J.D. Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain 39 (1989) 77-84
64. Morris M.J., Russell A.E., Kapoor V., Cain M.D., Elliott J.M., West M.J., et al. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv Syst 17 (1986) 143-149
65. Hernanz A., Medina S., de M.E., and Martin-Mola E. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients. Regul Pept 115 (2003) 19-24
66. Rosmaninho-Salgado J., Alvaro A.R., Grouzmann E., Duarte E.P., and Cavadas C. Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells. Peptides 28 (2007) 310-314
67. Taiwo O.B., and Taylor B.K. Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors. Pain 96 (2002) 353-363
68. Case J.P. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther 8 (2001) 123-143
69. Kiziltunc A., Cogalgil S., Ugur M., Avci B., and Akcay F. Sialic acid, transketolase and Na+, K+, ATPase in patients with rheumatoid arthritis. Clin Chem Lab Med 36 (1998) 289-293
70. Trujillo E., Varez de la R.D., Mobasheri A., Avila J., Gonzalez T., and Martin-Vasallo P. Sodium transport systems in human chondrocytes. I. Morphological and functional expression of the Na+, K(+)-ATPase alpha and beta subunit isoforms in healthy and arthritic chondrocytes. Histol Histopathol 14 (1999) 1011-1022
71. Foey A.D., Crawford A., and Hall N.D. Modulation of cytokine production by human mononuclear cells following impairment of Na, K-ATPase activity. Biochim Biophys Acta 1355 (1997) 43-49
72. Yildirim K., Senel K., Karatay S., Sisecioglu M., Kiziltunc A., Ugur M., et al. Serum E-selectin and erythrocyte membrane Na+K+ ATPase levels in patients with rheumatoid arthritis. Cell Biochem Funct 23 (2005) 285-289
73. Clausen T. Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83 (2003) 1269-1324
74. Yin W., Yin F.Z., Shen W.X., Cai B.C., and Hua Z.C. Requirement of hydrogen peroxide and Sp1 in the stimulation of Na, K-ATPase by low potassium in MDCK epithelial cells. Int J Biochem Cell Biol 40 (2008) 942-953
75. Zhou X., Yin W., Doi S.Q., Robinson S.W., Takeyasu K., and Fan X. Stimulation of Na, K-ATPase by low potassium requires reactive oxygen species. Am J Physiol Cell Physiol 285 (2003) C319-C326
76. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39 (2007) 44-84
77. Filippin L.I., Vercelino R., Marroni N.P., and Xavier R.M. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152 (2008) 415-422
78. Cedergren J., Forslund T., Sundqvist T., and Skogh T. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. J Rheumatol 34 (2007) 2162-2170
79. Yamada K., Nakamura T., and Utsumi H. Enhanced intraarticular free radical reactions in adjuvant arthritis rats. Free Radic Res 40 (2006) 455-460
80. Buttgereit F., Saag K.G., Cutolo M., da Silva J.A., and Bijlsma J.W. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 34 (2005) 14-21
81. Urbach V., Verriere V., Grumbach Y., Bousquet J., and Harvey B.J. Rapid anti-secretory effects of glucocorticoids in human airway epithelium. Steroids 71 (2006) 323-328
82. Lowenberg M., Stahn C., Hommes D.W., and Buttgereit F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73 (2008) 1025-1029
83. Stahn C., Lowenberg M., Hommes D.W., and Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275 (2007) 71-78
84. Ritter M., Fuerst J., Woll E., Chwatal S., Gschwentner M., Lang F., et al. Na(+)/H(+) exchangers: linking osmotic dysequilibrium to modified cell function. Cell Physiol Biochem 11 (2001) 1-18
85. Choi J.Y., Kim S.Y., Son E.J., Kim J.L., Shin J.H., Song M.H., et al. Dexamethasone increases fluid absorption via Na+/H+ exchanger (NHE) 3 activation in normal human middle ear epithelial cells. Eur J Pharmacol 536 (2006) 12-18
86. Lui K.E., Panchal A.S., Santhanagopal A., Dixon S.J., and Bernier S.M. Epidermal growth factor stimulates proton efflux from chondrocytic cells. J Cell Physiol 192 (2002) 102-112
87. Wang D., Zhang H., Lang F., and Yun C.C. Acute activation of NHE3 by dexamethasone correlates with activation of SGK1 and requires a functional glucocorticoid receptor. Am J Physiol Cell Physiol 292 (2007) C396-C404
88. Yun C.C., Chen Y., and Lang F. Glucocorticoid activation of Na(+)/H(+) exchanger isoform 3 revisited. The roles of SGK1 and NHERF2. J Biol Chem 277 (2002) 7676-7683
89. Gardner L.I., Maclachlan E.A., and Berman H. Effect of potassium deficiency on carbon dioxide, cation, and phosphate content of muscle, with a note on the carbon dioxide content of human muscle. J Gen Physiol 36 (1952) 153-159
90. Welt L.G., Hollander Jr. W., and Blythe W.B. The consequences of potassium depletion. J Chronic Dis 11 (1960) 213-254
91. Gardner G., and Furst D.E. Disease-modifying antirheumatic drugs. Potential effects in older patients. Drugs Aging 7 (1995) 420-437
92. Fox R.I. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 23 (1993) 82-91
93. Baum M., Moe O.W., Gentry D.L., and Alpern R.J. Effect of glucocorticoids on renal cortical NHE-3 and NHE-1 mRNA. Am J Physiol 267 (1994) F437-F442
94. Yun C.H., Gurubhagavatula S., Levine S.A., Montgomery J.L., Brant S.R., Cohen M.E., et al. Glucocorticoid stimulation of ileal Na+ absorptive cell brush border Na+/H+ exchange and association with an increase in message for NHE-3, an epithelial Na+/H+ exchanger isoform. J Biol Chem 268 (1993) 206-211
95. Muto S., Ebata S., Okada K., Saito T., and Asano Y. Glucocorticoid modulates Na+/H+ exchange activity in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int 57 (2000) 2319-2333
96. Milner P.I., Wilkins R.J., and Gibson J.S. The role of mitochondrial reactive oxygen species in pH regulation in articular chondrocytes. Osteoarthritis Cartilage 15 (2007) 735-742
97. 2 tension on pH homeostasis in equine articular chondrocytes. Arthritis Rheum 54 (2006) 3523-3532
98. Davies E.V., Campbell A.K., Williams B.D., and Hallett M.B. Single cell imaging reveals abnormal intracellular calcium signals within rheumatoid synovial neutrophils. Br J Rheumatol 30 (1991) 443-448
99. Wiontzek M., Matziolis G., Schuchmann S., Gaber T., Krocker D., Duda G., et al. Effects of dexamethasone and celecoxib on calcium homeostasis and expression of cyclooxygenase-2 mRNA in MG-63 human osteosarcoma cells. Clin Exp Rheumatol 24 (2006) 366-372